The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap: an observational cohort study
Authors:
Open Access
- 12 January 2022
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 22 (1) , 1-10
Abstract
Background: Asthma–chronic obstructive pulmonary disease (COPD) overlap (ACO) patients experience exacerbations more frequently than those with asthma or COPD alone. Since low diffusing capacity of the lung for carbon monoxide (DLCO) is known as a strong risk factor for severe exacerbation in COPD, DLCOor a transfer coefficient of the lung for carbon monoxide (KCO) is speculated to also be associated with the risk of exacerbations in ACO.Methods: This study was conducted as an observational cohort survey at the National Hospital Organization Fukuoka National Hospital. DLCOand KCOwere measured in 94 patients aged ≥ 40 years with a confirmed diagnosis of ACO. Multivariable-adjusted hazard ratios (HRs) for the exacerbation-free rate over one year were estimated and compared across the levels of DLCOand KCO.Results: Within one year, 33.3% of the cohort experienced exacerbations. After adjustment for potential confounders, low KCO(< 80% per predicted) was positively associated with the incidence of exacerbation (multivariable-adjusted HR = 3.71 (95% confidence interval 1.32–10.4)). The association between low DLCO(< 80% per predicted) and exacerbations showed similar trends, although it failed to reach statistical significance (multivariable-adjusted HR = 1.31 (95% confidence interval 0.55–3.11)).Conclusions: Low KCOwas a significant risk factor for exacerbations among patients with ACO. Clinicians should be aware that ACO patients with impaired KCOare at increased risk of exacerbations and that careful management in such a population is mandatory.Keywords
This publication has 29 references indexed in Scilit:
- Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous valuesRespiratory Investigation, 2014
- Examination of the Carbon Monoxide Diffusing Capacity (D l CO) in Relation to Its K co and V a ComponentsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- Impact of Altered Alveolar Volume on the Diffusing Capacity of the Lung for Carbon Monoxide in ObesityRespiration, 2010
- The overlap syndrome of asthma and COPD: what are its features and how important is it?Thorax, 2009
- An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and ExacerbationsAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Pulmonary Diffusing Capacity for Nitric Oxide During Exercise in Morbid ObesityObesity, 2008
- Effect of Circulatory Congestion on the Components of Pulmonary Diffusing Capacity in Morbid ObesityObesity, 2006
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Single Breath Diffusing Capacity for Carbon Monoxide in Stable AsthmaChest, 1994